Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

397
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
397
Birth Control Methods01:22

Birth Control Methods

5.7K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

992
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
992
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

998
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
998
Prodrugs01:30

Prodrugs

3.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.8K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

635
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
635

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone.

Geburtshilfe und Frauenheilkunde·2022
Same author

Dydrogesterone after 60 years: a glance at the safety profile.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2021
Same author

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone.

Geburtshilfe und Frauenheilkunde·2021
Same author

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference.

Drugs in context·2020
Same author

Pregnancy rates after slow-release insemination (SRI) and standard bolus intrauterine insemination (IUI) - A multicentre randomised, controlled trial.

Scientific reports·2020
Same author

Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2020

Related Experiment Video

Updated: Dec 31, 2025

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
09:26

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

Published on: November 17, 2011

16.5K

Progestogen-only pills: which progestogen would be ideal.

Christian Egarter1

  • 1Medical University Vienna, Department of Gynecological Endocrinology & Reproductive Medicine, Waehringer Guertel 18-201090 Vienna, Austria.

Hormone Molecular Biology and Clinical Investigation
|January 11, 2020
PubMed
Summary

Combined hormonal contraceptives increase thromboembolism risk. Progestin-only pills may offer a safer alternative for women ineligible for combined options, with newer progestogens showing potential benefits.

Keywords:
desogestreldrospirenonelevonorgestrelnorethindroneprogestogen-only-pill

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K
Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
06:49

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

2.1K

Related Experiment Videos

Last Updated: Dec 31, 2025

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
09:26

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

Published on: November 17, 2011

16.5K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K
Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
06:49

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

2.1K

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Thromboembolism Research

Background:

  • Combined hormonal contraceptives (estrogen-progestogen) are linked to increased venous and arterial thromboembolism risks.
  • Thromboembolic events, though rare in reproductive-age women, include stroke and myocardial infarction.
  • Progestin-only pills were historically considered to have no associated thromboembolic risk.

Purpose of the Study:

  • To evaluate the thromboembolic risk associated with different types of hormonal contraceptives.
  • To identify safer contraceptive alternatives for women at higher risk.
  • To explore the potential benefits of newer progestogens like drospirenone.

Main Methods:

  • Review of existing literature on hormonal contraceptive use and thromboembolic events.
  • Comparison of risk profiles between combined hormonal contraceptives and progestin-only pills.
  • Analysis of progestogen properties, including androgenic and anti-mineralocorticoid effects.

Main Results:

  • Combined hormonal contraceptives show a 2-3 fold increased risk of venous and 2-fold increased risk of arterial thromboembolism.
  • Progestin-only pills historically presented no increased thromboembolic risk.
  • Modern progestogens, such as drospirenone, may offer additional benefits due to their properties.

Conclusions:

  • Progestin-only pills are valuable options for women ineligible for combined hormonal contraceptives due to thromboembolic risk.
  • Further clinical studies are needed to demonstrate the favorable aspects of newer progestogens like drospirenone.
  • Risk-benefit assessment is crucial when selecting hormonal contraceptives.